These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11566589)

  • 1. QSAR models for reproductive toxicity and endocrine disruption in regulatory use--a preliminary investigation.
    Jensen GE; Niemelä JR; Wedebye EB; Nikolov NG
    SAR QSAR Environ Res; 2008; 19(7-8):631-41. PubMed ID: 19061080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR modeling: where have you been? Where are you going to?
    Cherkasov A; Muratov EN; Fourches D; Varnek A; Baskin II; Cronin M; Dearden J; Gramatica P; Martin YC; Todeschini R; Consonni V; Kuz'min VE; Cramer R; Benigni R; Yang C; Rathman J; Terfloth L; Gasteiger J; Richard A; Tropsha A
    J Med Chem; 2014 Jun; 57(12):4977-5010. PubMed ID: 24351051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Structure-Activity Relationship (QSAR) Studies on the Toxic Effects of Nitroaromatic Compounds (NACs): A Systematic Review.
    Huang T; Sun G; Zhao L; Zhang N; Zhong R; Peng Y
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Benefits of Imputation over QSAR Methods in Toxicology Data Modeling.
    Whitehead TM; Strickland J; Conduit GJ; Borrel A; Mucs D; Baskerville-Abraham I
    J Chem Inf Model; 2024 Apr; 64(7):2624-2636. PubMed ID: 38091381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usage of model combination in computational toxicology.
    Rodríguez-Belenguer P; March-Vila E; Pastor M; Mangas-Sanjuan V; Soria-Olivas E
    Toxicol Lett; 2023 Nov; 389():34-44. PubMed ID: 37890682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Activity/Property Prediction from Chemical Structures.
    Saunders A; Harrington PB
    Crit Rev Anal Chem; 2024 Jul; 54(1):135-147. PubMed ID: 35482792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Mechanistic and Toxicokinetic Information in Predictive Models of Cholestasis.
    Rodríguez-Belenguer P; Mangas-Sanjuan V; Soria-Olivas E; Pastor M
    J Chem Inf Model; 2024 Apr; 64(7):2775-2788. PubMed ID: 37660324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dose disrupts the pathway: application of paracelsus principle to mechanistic toxicology.
    Suvorov A
    Toxicol Sci; 2024 May; ():. PubMed ID: 38713198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering active sites in peptide Ala-Val-Thr-Phe that counter 2,2-azobis(2-methylpropanimidamidine)dihydrochloride-induced oxidative stress in HepG2 cells.
    Liang J; Wang Q; Liu J; Huang G; Liang C; Liu H; Ma L
    RSC Adv; 2020 Jun; 10(41):24444-24453. PubMed ID: 35516203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2.
    Cuesta SA; Mora JR; Márquez EA
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33669720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic insights into the specificity of human cytosolic sulfotransferase 2A1 (hSULT2A1) for hydroxylated polychlorinated biphenyls through the use of fluoro-tagged probes.
    Ekuase EJ; van 't Erve TJ; Rahaman A; Robertson LW; Duffel MW; Luthe G
    Environ Sci Pollut Res Int; 2016 Feb; 23(3):2119-27. PubMed ID: 26165989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity testing in the 21st century: a vision and a strategy.
    Krewski D; Acosta D; Andersen M; Anderson H; Bailar JC; Boekelheide K; Brent R; Charnley G; Cheung VG; Green S; Kelsey KT; Kerkvliet NI; Li AA; McCray L; Meyer O; Patterson RD; Pennie W; Scala RA; Solomon GM; Stephens M; Yager J; Zeise L
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):51-138. PubMed ID: 20574894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds.
    Boik JC; Newman RA
    BMC Pharmacol; 2008 Jun; 8():12. PubMed ID: 18554402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-toxicity relationships of nitroaromatic compounds.
    Isayev O; Rasulev B; Gorb L; Leszczynski J
    Mol Divers; 2006 May; 10(2):233-45. PubMed ID: 16710810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
    Ekins S; Boulanger B; Swaan PW; Hupcey MA
    Mol Divers; 2002; 5(4):255-75. PubMed ID: 12549676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
    Ekins S; Boulanger B; Swaan PW; Hupcey MA
    J Comput Aided Mol Des; 2002; 16(5-6):381-401. PubMed ID: 12489686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.
    Soffers AE; Boersma MG; Vaes WH; Vervoort J; Tyrakowska B; Hermens JL; Rietjens IM
    Toxicol In Vitro; 2001; 15(4-5):539-51. PubMed ID: 11566589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing.
    Péry AR; Desmots S; Mombelli E
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From QSAR to QSIIR: searching for enhanced computational toxicology models.
    Zhu H
    Methods Mol Biol; 2013; 930():53-65. PubMed ID: 23086837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.